| Document Date: 2014-11-11 06:38:10
Open Document File Size: 50,23 KBShare Result on Facebook
City Zurich / / Company Swiss Pharma GmbH / Venus Pharma GmbH / Venus Remedies Limited / / Country Germany / Switzerland / France / Saudi Arabia / Italy / Australia / United Kingdom / Spain / South Africa / / Currency USD / / Event FDA Phase / / IndustryTerm generic product / pharmaceutical / / MedicalCondition pneumonia / severe bacterial infections / broncho-pulmonary infections / postpartum infections / skin infections / urinary tract infections / cystic fibrosis / soft tissue infections / acute bacterial meningitis / intra-abdominal infections / / Organization European Union / / Product Meropenem / Meropenem 500 mg / critically important antibiotic drug / /
SocialTag |
11th November, 2014 Venus Receives Market Authorization for Meropenem from Switzerland (SWISSMEDIC) Venus Remedies Limited, a leading research based global pharmaceutical company, achieved yet another landmark by receivi